Target intelligence / Profile preview

UDP-xylose 4-epimerase (UXE)

Target
UXE
Molecular classification
Enzyme [1, 5], Epimerase [1, 7], Isomerase [13, 17]
01

Overview

UDP-xylose 4-epimerase (UXE), also known as UDP-L-arabinose 4-epimerase, is an enzyme that catalyzes the reversible interconversion of UDP-D-xylose and UDP-L-arabinose [1, 3, 5]. This enzyme is primarily found in plants, fungi, and certain bacteria, where it plays a critical role in the biosynthesis of cell wall polysaccharides and extracellular glycans [5, 6, 30]. In plants, it provides the UDP-L-arabinose required for the synthesis of pectins and hemicelluloses, while in pathogenic microorganisms, it is involved in the production of surface polysaccharides essential for biofilm formation and virulence [1, 3, 11]. Because UXE is not present in humans, it is considered a promising target for the development of novel anti-infective agents, particularly against antibiotic-resistant bacteria and pathogenic fungi [1, 11]. Inhibition of this enzyme can disrupt the structural integrity of the pathogen or reduce its ability to form protective biofilms, thereby enhancing the host's immune response or the efficacy of co-administered treatments [3, 11]. Current research efforts are focused on identifying selective small-molecule inhibitors that can distinguish between the pathogen's UXE and human UDP-sugar epimerases, such as UDP-glucose 4-epimerase (GALE), to minimize potential off-target effects [4, 11].

Other names
UDP-L-arabinose 4-epimeraseUridine diphosphate xylose 4-epimeraseUXE1ARA1Uxe
02

Mechanism of action

Inhibition of the interconversion between UDP-xylose and UDP-arabinose, which disrupts the synthesis of essential cell wall or surface polysaccharides in pathogens [1, 11].

03

Biological functions

Carbohydrate metabolism [1, 3, 5]Cell wall biosynthesis [5, 6, 30]Biofilm formation [1, 3]Polysaccharide biosynthesis [1, 3, 20]
04

Disease associations

Infection [1, 3, 11]Bacterial infection [1, 3]Fungal infection [11]
05

Safety considerations

Potential cross-reactivity with human UDP-sugar epimerases (e.g., GALE) [4, 11]Selectivity challenges in drug design [11]

Beyond the preview

Go deeper on UDP-xylose 4-epimerase (UXE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UDP-xylose 4-epimerase (UXE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call